scholarly journals LIVECHART patient‐reported outcome tool for botulinum toxin treatment in cervical dystonia

2021 ◽  
Author(s):  
Chuenchom Chueluecha ◽  
A. Peter Moore
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Patient Reported Outcome ◽  
Patient Reported ◽  
Botulinum Toxin Treatment ◽  
Outcome Tool

Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal

2021 ◽  
Author(s):  
Luca Marsili ◽  
Matteo Bologna ◽  
Joseph Jankovic ◽  
Carlo Colosimo
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Efficacy And Safety ◽  
Term Efficacy ◽  
Botulinum Toxin Treatment

224. Utilization of an automated SMS-based electronic patient-reported outcome tool in spinal surgery patients

2021 ◽  
Vol 21 (9) ◽  
pp. S115
Author(s):  
Rami Elsabeh ◽  
Katie Delgado ◽  
Kaushik Das ◽  
Krishn M. Sharma ◽  
Ezriel Kornel ◽  
...  
Keyword(s):  
Spinal Surgery ◽  
Patient Reported Outcome ◽  
Patient Reported ◽  
Outcome Tool

Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia

2012 ◽  
Vol 15 (3) ◽  
pp. 419-423 ◽  
Author(s):  
Kapil D. Sethi ◽  
Ramon Rodriguez ◽  
Babajide Olayinka
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Botulinum Toxin Treatment

scholarly journals Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo?

2018 ◽  
Vol 56 ◽  
pp. 16-19 ◽  
Author(s):  
Gonçalo S. Duarte ◽  
Filipe B. Rodrigues ◽  
Joaquim J. Ferreira ◽  
João Costa
Keyword(s):  
Botulinum Toxin ◽  
Adverse Events ◽  
Cervical Dystonia ◽  
Botulinum Toxin Treatment

57. The use of electromyography in botulinum toxin treatment of cervical dystonia

Toxicon ◽  
2015 ◽  
Vol 93 ◽  
pp. S19
Author(s):  
Marina A.J. de Koning-Tijssen
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Botulinum Toxin Treatment

Quality of Life after Radioembolization for Hepatocellular Carcinoma Using a Digital Patient-Reported Outcome Tool

2020 ◽  
Vol 31 (2) ◽  
pp. 311-314.e1 ◽  
Author(s):  
Riad Salem ◽  
Shahzeb Hassan ◽  
Robert J. Lewandowski ◽  
Karen Grace ◽  
Robert C.G. Martin ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Hepatocellular Carcinoma ◽  
Patient Reported Outcome ◽  
Patient Reported ◽  
Outcome Tool

scholarly journals Cause or effect: Altered brain and network activity in cervical dystonia is partially normalized by botulinum toxin treatment

2019 ◽  
Vol 22 ◽  
pp. 101792 ◽  
Author(s):  
Stefan Brodoehl ◽  
Franziska Wagner ◽  
Tino Prell ◽  
Carsten Klingner ◽  
O.W. Witte ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Cervical Dystonia ◽  
Network Activity ◽  
Botulinum Toxin Treatment

Short-Term Outcomes of Open Hip Preservation Surgery for Symptomatic Extraarticular Femoroacetabular Impingement

2017 ◽  
Vol 27 (6) ◽  
pp. 599-607 ◽  
Author(s):  
Benjamin F. Ricciardi ◽  
Kara G. Fields ◽  
Catherine Wentzel ◽  
Bryan T. Kelly ◽  
Ernest L. Sink
Keyword(s):  
Treatment Failure ◽  
Minimum Clinically Important Difference ◽  
Patient Reported Outcome ◽  
Harris Hip Score ◽  
Short Term ◽  
Specific Patient ◽  
Patient Reported ◽  
Open Treatment ◽  
Outcome Tool

Introduction The purposes of this study were to describe: (i) short-term disease-specific patient-reported outcome scores (PROMs); and (ii) factors associated with reoperation or treatment failure in patients undergoing open hip preservation surgery for symptomatic extraarticular FAI. Methods Patients undergoing open hip preservation surgery for symptomatic extraarticular FAI were identified from a prospective, single-centre hip preservation registry (n = 51 patients; median clinical follow-up 24 [range 11-49] months). Hip-specific PROMs were assessed preoperatively, 6 months, and each year subsequently. Patients undergoing reoperation or treatment failure (<10 point improvement in iHOT-33 postoperatively) over the study period were identified. Preoperative associated factors were explored on a univariate basis. Results International Hip Outcome Tool-33 (iHOT-33) improved from 33 (standard deviation [SD] 18) to 62 (26) at most recent follow-up and 76% of patients improved by minimum clinically important difference (MCID). Harris Hip Score improved from 53 (15) to 75 (17) at most recent follow-up and 79% of patients improved by MCID. Hip Outcome Score (HOS) Sport improved from 45 (26) to 66 (28) at most recent follow-up and 60% of patients improved by MCID. Continued improvements in mean follow-up scores were seen from 1 year to 2 years. Overall, 7 patients underwent reoperation and 9 patients failed to improve by MCID. Preoperative HOS Sport was higher in patients experiencing reoperation or treatment failure (58 [SD 19] vs. 40 [SD 27] respectively; p = 0.03). No other associated demographic, physical examination, or radiographic factors were found. Conclusions Open treatment of extraarticular FAI results in short-term improvements in hip-specific PROMs in most patients. Higher HOS Sport scores were associated with reoperation or treatment failure. Longer-term follow-up is necessary to define maximum improvements in this challenging patient population.

Patient-Reported Benefit From Botulinum Toxin Treatment for Essential Blepharospasm

2013 ◽  
Vol 29 (3) ◽  
pp. 196-197 ◽  
Author(s):  
Richard M. H. Lee ◽  
Haziq R. Chowdhury ◽  
Jonathan N. Hyer ◽  
Henry B. Smith ◽  
Carole A. Jones
Keyword(s):  
Botulinum Toxin ◽  
Essential Blepharospasm ◽  
Patient Reported ◽  
Botulinum Toxin Treatment
Sign in / Sign up

Export Citation Format

Share Document